Covid: No safety concerns found with Oxford vaccine trial after Brazil death
Published
Oxford University says a review has found no safety concerns after the Brazilian volunteer's death.
Full ArticlePublished
Oxford University says a review has found no safety concerns after the Brazilian volunteer's death.
Full ArticleMedexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..
A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University,..